Myocardial ischemia-reperfusion injury; Molecular mechanisms and prevention
Microvascular Research · 2023-09 · 149 · 104565
DOI: 10.1016/j.mvr.2023.104565 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microvascular Research, 2023-09. Verfasst von Yang Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Hospital of Shandong University of TCM, Jinan 250011, China. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Myocardial Infarction, Heart Failure. Die Arbeit wurde bisher 129-mal zitiert (Crossref) und nennt 252 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Cardiovascular diseases are one of the leading causes of mortality in developed countries. Among cardiovascular disorders, myocardial infarction remains a life-threatening problem predisposing to the development and progression of ischemic heart failure. Ischemia/reperfusion (I/R) injury is a critical cause of myocardial injury. In recent decades, many efforts have been made to find the molecular and cellular mechanisms underlying the development of myocardial I/R injury and post-ischemic remodeling. Some of these mechanisms are mitochondrial dysfunction, metabolic alterations, inflammation, high production of ROS, and autophagy deregulation. Despite continuous efforts, myocardial I/R injury remains a major challenge in medical treatments of thrombolytic therapy, heart disease, primary percutaneous coronary intervention, and coronary arterial bypass grafting. The development of effective therapeutic strategies to reduce or prevent myocardial I/R injury is of great clinical significance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Affiliated Hospital of Shandong University of TCM, Jinan 250011, China.
- The Affiliated Hospital of Shandong University of TCM, Jinan 250011, China; First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan 250355, China. Electronic address: ajmermaid@163.com.
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China. Electronic address: ElninoZ9@163.com.
Förderung
- Natural Science Foundation of Shandong Province
Zitieren
APA
Liu, Y., Li, L., Wang, Z., Zhang, J., & Zhou, Z. (2023). Myocardial ischemia-reperfusion injury; Molecular mechanisms and prevention. Microvascular Research, 149, 104565. https://doi.org/10.1016/j.mvr.2023.104565
Vancouver
Liu Y, Li L, Wang Z, Zhang J, Zhou Z. Myocardial ischemia-reperfusion injury; Molecular mechanisms and prevention. Microvascular Research. 2023;149:104565. doi:10.1016/j.mvr.2023.104565
BibTeX
@article{Liu2023,
author = {Liu, Yang and Li, Lei and Wang, Zhen and Zhang, Juan and Zhou, Zhou},
title = {Myocardial ischemia-reperfusion injury; Molecular mechanisms and prevention},
journal = {Microvascular Research},
year = {2023},
volume = {149},
pages = {104565},
doi = {10.1016/j.mvr.2023.104565}
}
EUVIMED